HSBC Holdings’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $93.4M | Buy |
166,251
+6,616
| +4% | +$4.24M | 0.05% | 352 |
|
|
2025
Q4 | $108M | Sell |
159,635
-33,505
| -17% | -$22.8M | 0.06% | 310 |
|
|
2025
Q3 | $123M | Sell |
193,140
-31,010
| -14% | -$18.8M | 0.07% | 265 |
|
|
2025
Q2 | $120M | Sell |
224,150
-123,463
| -36% | -$59M | 0.07% | 268 |
|
|
2025
Q1 | $146M | Sell |
347,613
-39,870
| -10% | -$17.3M | 0.09% | 214 |
|
|
2024
Q4 | $160M | Buy |
387,483
+43,225
| +13% | +$19M | 0.09% | 193 |
|
|
2024
Q3 | $174M | Buy |
344,258
+72,509
| +27% | +$35.2M | 0.1% | 183 |
|
|
2024
Q2 | $133M | Sell |
271,749
-29,266
| -10% | -$14.7M | 0.08% | 221 |
|
|
2024
Q1 | $162M | Buy |
301,015
+103,347
| +52% | +$56.5M | 0.11% | 173 |
|
|
2023
Q4 | $110M | Buy |
197,668
+54,024
| +38% | +$25.4M | 0.1% | 206 |
|
|
2023
Q3 | $62.8M | Sell |
143,644
-7,961
| -5% | -$3.97M | 0.07% | 312 |
|
|
2023
Q2 | $76M | Buy |
151,605
+20,489
| +16% | +$9.82M | 0.08% | 262 |
|
|
2023
Q1 | $65.5M | Sell |
131,116
-13,608
| -9% | -$6.51M | 0.08% | 260 |
|
|
2022
Q4 | $58.9M | Buy |
144,724
+43,856
| +43% | +$17M | 0.07% | 304 |
|
|
2022
Q3 | $33.2M | Sell |
100,868
-4,262
| -4% | -$1.57M | 0.05% | 371 |
|
|
2022
Q2 | $37.2M | Buy |
105,130
+4,541
| +5% | +$1.85M | 0.05% | 373 |
|
|
2022
Q1 | $55.1M | Sell |
100,589
-4,185
| -4% | -$2.2M | 0.07% | 286 |
|
|
2021
Q4 | $69.2M | Buy |
104,774
+1,136
| +1% | +$713K | 0.06% | 298 |
|
|
2021
Q3 | $64.8M | Sell |
103,638
-4,990
| -5% | -$3.35M | 0.07% | 267 |
|
|
2021
Q2 | $68.8M | Buy |
108,628
+15,644
| +17% | +$8.64M | 0.07% | 252 |
|
|
2021
Q1 | $45.1M | Sell |
92,984
-21,009
| -18% | -$10.5M | 0.05% | 348 |
|
|
2020
Q4 | $56.8M | Buy |
113,993
+20,952
| +23% | +$9.37M | 0.08% | 253 |
|
|
2020
Q3 | $36.4M | Buy |
93,041
+7,034
| +8% | +$2.6M | 0.06% | 301 |
|
|
2020
Q2 | $28.4M | Sell |
86,007
-16,021
| -16% | -$4.64M | 0.05% | 331 |
|
|
2020
Q1 | $24.7M | Sell |
102,028
-21,407
| -17% | -$5.59M | 0.06% | 305 |
|
|
2019
Q4 | $32.6M | Buy |
123,435
+57,061
| +86% | +$15M | 0.06% | 343 |
|
|
2019
Q3 | $18.1M | Buy |
66,374
+13,274
| +25% | +$3.69M | 0.03% | 577 |
|
|
2019
Q2 | $14.6M | Sell |
53,100
-205
| -0.4% | -$50.5K | 0.03% | 643 |
|
|
2019
Q1 | $11.9M | Buy |
53,305
+5,959
| +13% | +$1.23M | 0.02% | 717 |
|
|
2018
Q4 | $8.81M | Sell |
47,346
-4,606
| -9% | -$944K | 0.02% | 882 |
|
|
2018
Q3 | $13M | Sell |
51,952
-8,874
| -15% | -$2.15M | 0.02% | 747 |
|
|
2018
Q2 | $13.3M | Sell |
60,826
-42,575
| -41% | -$8.77M | 0.02% | 677 |
|
|
2018
Q1 | $19.8M | Buy |
103,401
+22,470
| +28% | +$4.15M | 0.03% | 552 |
|
|
2017
Q4 | $12.7M | Sell |
80,931
-11,650
| -13% | -$1.83M | 0.02% | 614 |
|
|
2017
Q3 | $14.4M | Buy |
92,581
+16,893
| +22% | +$2.67M | 0.02% | 667 |
|
|
2017
Q2 | $12.2M | Buy |
75,688
+27,121
| +56% | +$4.4M | 0.02% | 679 |
|
|
2017
Q1 | $7.52M | Buy |
48,567
+34,318
| +241% | +$4.73M | 0.02% | 821 |
|
|
2016
Q4 | $1.67M | Sell |
14,249
-4,506
| -24% | -$514K | ﹤0.01% | 1257 |
|
|
2016
Q3 | $2.11M | Sell |
18,755
-1,512
| -7% | -$159K | 0.01% | 1169 |
|
|
2016
Q2 | $1.88M | Buy |
20,267
+11,047
| +120% | +$949K | 0.01% | 1203 |
|
|
2016
Q1 | $723K | Sell |
9,220
-469
| -5% | -$33.8K | ﹤0.01% | 1426 |
|
|
2015
Q4 | $707K | Buy |
9,689
+2,555
| +36% | +$182K | ﹤0.01% | 1568 |
|
|
2015
Q3 | $530K | Buy |
7,134
+1,417
| +25% | +$101K | ﹤0.01% | 1380 |
|
|
2015
Q2 | $367K | Buy |
5,717
+163
| +3% | +$11.3K | ﹤0.01% | 1528 |
|
|
2015
Q1 | $429K | Buy |
+5,554
| New | +$432K | ﹤0.01% | 1606 |
|
|
2014
Q2 | – | Sell |
-3,336
| Closed | -$202K | – | 1779 |
|
|
2014
Q1 | $202K | Buy |
+3,336
| New | +$199K | ﹤0.01% | 1638 |
|
Other funds holding IDXX
VCM
VPM
HSBC Holdings's IDXX Position: Q1 2026 in Review
HSBC Holdings increased its Idexx Laboratories (IDXX) stake by 4.1% in Q1 2026, buying an estimated $4.24M and bringing the position to 166,251 shares worth $93.4M. The position accounts for 0.05% of the portfolio, ranked #352.
HSBC Holdings first reported a position in IDXX in Q1 2014 and has held it in 46 quarters since. The position peaked at $174M in Q3 2024. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- HSBC Holdings held 166,251 shares of Idexx Laboratories worth $93.4M as of Q1 2026.
- HSBC Holdings bought 6,616 Idexx Laboratories shares in Q1 2026, an estimated $4.24M.
- Idexx Laboratories made up 0.05% of HSBC Holdings's portfolio in Q1 2026, its #352 holding.
- HSBC Holdings first reported a position in Idexx Laboratories in Q1 2014 and has held it in 46 quarters since.
- HSBC Holdings's Idexx Laboratories position peaked at $174M in Q3 2024.
- 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.